Show simple item record

dc.contributor.authorPérez Rodríguez, Aitzol ORCID
dc.contributor.authorEraso Barrio, María Elena ORCID
dc.contributor.authorQuindós Andrés, Guillermo
dc.contributor.authorMateo Alesanco, Estibaliz ORCID
dc.date.accessioned2022-08-31T06:50:33Z
dc.date.available2022-08-31T06:50:33Z
dc.date.issued2022-08-17
dc.identifier.citationInternational Journal of Molecular Sciences 23(16) : (2022) // Article ID 9264es_ES
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10810/57357
dc.description.abstract[EN] Mycoses are accountable for millions of infections yearly worldwide. Invasive candidiasis is the most usual, presenting a high morbidity and mortality. Candida albicans remains the prevalent etiologic agent, but the incidence of other species such as Candida parapsilosis, Candida glabrata and Candida auris keeps increasing. These pathogens frequently show a reduced susceptibility to commonly used antifungal drugs, including polyenes, triazoles and echinocandins, and the incidence of emerging multi-drug-resistant strains of these species continues to increase. Therefore, the need to search for new molecules that target these pathogenic species in a different manner is now more urgent than ever. Nature is an almost endless source of interesting new molecules that could meet this need. Among these molecules, antimicrobial peptides, present in different sources in nature, possess some advantages over conventional antifungal agents, even with their own drawbacks, and are considered as a promising pharmacological option against a wide range of microbial infections. In this review, we describe 20 antimicrobial peptides from different origins that possess an activity against Candida.es_ES
dc.description.sponsorshipThis research was funded by the Spanish Ministry of Science and Innovation (PID2020-117983RB-I00) and by the Consejería de Educación, Universidades e Investigación of Gobierno Vasco-Eusko Jaurlaritza (IT1607-22). A.P.-R. was funded by a Ph.D. grant from the University of the Basque Country (PIF17/167).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/PID2020-117983RB-I00es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectfungal infectionses_ES
dc.subjectcandidiasises_ES
dc.subjectmicrobial resistancees_ES
dc.subjectantifungal peptideses_ES
dc.titleAntimicrobial Peptides with Anti-Candida Activityes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2022-08-25T11:19:45Z
dc.rights.holder© 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/23/16/9264es_ES
dc.identifier.doi10.3390/ijms23169264
dc.departamentoesInmunología, microbiología y parasitología
dc.departamentoeuImmunologia, mikrobiologia eta parasitologia


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Except where otherwise noted, this item's license is described as © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).